Page 1 of Clinical Trials for "Bendamustine", 141 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia
Last Updated: February 15, 2012
Condition(s): Chronic Lymphocytic Leukemia (CLL)
2
Recruiting
Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia
Last Updated: May 3, 2012
Condition(s): Indolent Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia
3
Recruiting
Conditioning Regimen of Bendamustine and Melphalan Followed by Transplant in Patients With Multiple Myeloma
Last Updated: November 4, 2010
Condition(s): Multiple Myeloma
4
Recruiting
Ofatumumab and Bendamustine for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Last Updated: April 3, 2012
Condition(s): Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
5
Recruiting
Bendamustine, Wkly Bortezomib, Lenalidomide and Dexamethasone for Multiple Myeloma
Last Updated: December 1, 2011
Condition(s): Multiple Myeloma
6
Not yet recruiting
A Randomized, Double-Blind and Placebo-Controlled Study of GS-1101 in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Last Updated: March 30, 2012
Condition(s): Chronic Lymphocytic Leukemia
7
Recruiting
Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)
Last Updated: May 17, 2012
Condition(s): Leukaemia, Lymphocytic, Chronic
8
Recruiting
Combination of Pentostatin, Bendamustine and Ofatumumab for Treatment of Chronic Lymphocytic Leukemia and Lymphoma
Last Updated: January 6, 2012
Condition(s): Chronic Lymphocytic Leukemia; B-Cell Non-Hodgkin's Lymphoma
9
Recruiting
Fludarabine, Bendamustine and Rituximab Conditioning for Patients With Lymphoid Malignancies
Last Updated: April 4, 2012
Condition(s): Leukemia; Lymphoma
10
Recruiting
Dexamethasone, Ofatumumab and Bendamustine (DOT) First-line in Mantle-cell Lymphoma(MCL)
Last Updated: September 12, 2011
Condition(s): Lymphoma, Mantle-Cell
11
Recruiting
Ofatumumab and Bendamustine Combination Therapy Compared With Bendamustine Monotherapy in Indolent B-cell Non-Hodgkin's Lymphoma (NHL) Unresponsive to Rituximab or a Rituximab-Containing Regimen
Last Updated: March 15, 2012
Condition(s): Lymphoma, Non-Hodgkin; Lymphoma, Follicular
12
Terminated
Bendamustine in Acute Leukemia and MDS
Last Updated: March 15, 2012
Condition(s): Acute Myeloid Leukemia; Myelodysplastic Syndrome; Acute Lymphoblastic Leukemia; Chronic Myeloid Leukemia
13
Active, not recruiting
Bendamustine, Mitoxantrone, and Rituximab (BMR) for Patients With Untreated High Risk Follicular Lymphoma
Last Updated: January 4, 2012
Condition(s): Follicular Lymphoma
14
Recruiting
Bendamustine and Bevacizumab for Advanced Cancers
Last Updated: March 15, 2012
Condition(s): Advanced Cancer
15
Withdrawn
PH2 Trial in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) With a Combination of Bendamustine & Ofatumumab
Last Updated: July 19, 2011
Condition(s): Chronic Lymphocytic Leukemia (CLL)
16
Completed
Bendamustine in Patients With Refractory or Relapsed T-cell Lymphoma
Last Updated: June 8, 2011
Condition(s): T-cell Lymphoma
17
Terminated
Clinical Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia With a Combination of Bendamustine and Ofatumumab
Last Updated: July 19, 2011
Condition(s): Chronic Lymphocytic Leukemia (CLL)
18
Recruiting
Fludarabine, Bendamustine, and Rituximab (FBR) in Chronic Lymphocytic Leukemia (CLL)
Last Updated: February 14, 2012
Condition(s): Leukemia
19
Withdrawn
Study of Dasatinib and Bendamustine in Chronic Lymphocytic Leukemia
Last Updated: January 24, 2011
Condition(s): Chronic Lymphocytic Leukemia
20
Recruiting
Bendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Last Updated: May 24, 2012
Condition(s): Diffuse Large B-Cell Lymphoma; Lymphoma, Diffuse Large-Cell; Diffuse Large-Cell Lymphoma; Lymphoma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?intr=%22Bendamustine%22

Page 1 of Clinical Trials for "Bendamustine", 141 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About